***Background.*** Influenza is a common cause of community-acquired pneumonia (CAP). Data on the use of influenza antiviral treatment among patients hospitalized with all-cause CAP are limited.

***Methods.*** Adults ≥18 years old hospitalized with CAP were enrolled year-round at 5 hospitals in Chicago and Nashville. Clinicians ordered influenza tests (rapid test, direct fluorescent antigen, or polymerase chain reaction \[PCR\]) and prescribed antivirals per clinical judgment. Nasopharyngeal /oropharyngeal specimens for influenza PCR testing were systematically collected for the study but results were unavailable to clinicians. Treatment was defined as influenza antiviral agent receipt during hospitalization for any period of time. We compared factors associated with receipt and non-receipt of treatment during influenza season (October − April in each year).

***Results.*** From January 2010 − June 2012, we enrolled 2323 adults with CAP. Of 1491 (64%) adults enrolled during influenza season, 180 (12%) received treatment. Clinicians ordered influenza tests in 583 (39%) patients (96% were PCR); 37/48 (77%) with a positive result received antivirals. Study testing revealed 100 influenza positive cases, 41 of whom received antivirals. Compared with those who did not receive treatment, adults who received treatment were younger, admitted earlier during illness, less likely to have a comorbidity, and more likely to need intensive care unit (ICU) admission or mechanical ventilation.

  Characteristic                                           Receipt of treatment (n=180) No. (%)   Non-receipt of treatment (n=1311) No. (%)   P value
  -------------------------------------------------------- -------------------------------------- ------------------------------------------- ---------
  Median age (interquartile range \[IQR\]) years           54 (41-66)                             58 (47-71)                                  \<0.01
  Median days from illness onset to admission (IQR)        3 (2−6)                                4 (2−8)                                     0.03
  Any comorbidity                                          146 (81)                               1163 (89)                                   \<0.01
  Positive clinician-ordered influenza test/total tested   37/129 (29)                            11/454 (2)                                  \<0.01
  ICU admission                                            68 (38)                                242 (19)                                    \<0.01
  Invasive mechanical ventilation                          32/68 (47)                             59/242 (24)                                 \<0.01

***Conclusion.*** Among adults hospitalized with all-cause CAP, receipt of influenza antiviral treatment was low and associated with having a positive influenza result available to clinicians, presenting earlier in course of illness, and with severe disease. Reasons for the underutilization of antiviral treatment warrant exploration.
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